114 related articles for article (PubMed ID: 25407452)
1. [Genomics from bench to bedside: a change in perspective].
Bourgain C
Med Sci (Paris); 2014 Nov; 30 Spec No 2():14-7. PubMed ID: 25407452
[TBL] [Abstract][Full Text] [Related]
2. Pharmacogenetics of Warfarin Therapy.
Ruff CT
Clin Chem; 2018 Nov; 64(11):1558-1559. PubMed ID: 29941467
[No Abstract] [Full Text] [Related]
3. Pharmacogenetics of warfarin: current status and future challenges.
Wadelius M; Pirmohamed M
Pharmacogenomics J; 2007 Apr; 7(2):99-111. PubMed ID: 16983400
[TBL] [Abstract][Full Text] [Related]
4. Dynamic pharmacogenetic models in anticoagulation therapy.
Bon Homme M; Reynolds KK; Valdes R; Linder MW
Clin Lab Med; 2008 Dec; 28(4):539-52. PubMed ID: 19059061
[TBL] [Abstract][Full Text] [Related]
5. [Pharmacogenetic algorithms for predicting the appropriate dose of vitamin K antagonists: are they still useful?].
Mundi S; Distante A; De Caterina R
G Ital Cardiol (Rome); 2014 Oct; 15(10):546-60. PubMed ID: 25424019
[TBL] [Abstract][Full Text] [Related]
6. Warfarin pharmacogenetics: to genotype or not to genotype, that is the question.
Cavallari LH; Nutescu EA
Clin Pharmacol Ther; 2014 Jul; 96(1):22-4. PubMed ID: 24942399
[TBL] [Abstract][Full Text] [Related]
7. Refining the use of warfarin through genetic testing.
Lee SC
Int Angiol; 2008 Aug; 27(4):271-3. PubMed ID: 18677287
[No Abstract] [Full Text] [Related]
8. Prediction of warfarin dose: why, when and how?
Eriksson N; Wadelius M
Pharmacogenomics; 2012 Mar; 13(4):429-40. PubMed ID: 22379999
[TBL] [Abstract][Full Text] [Related]
9. Q: Should we use pharmacogenetic testing when prescribing warfarin?
Rouse M; Cristiani C; Teng KA
Cleve Clin J Med; 2013 Aug; 80(8):483-6. PubMed ID: 23908104
[No Abstract] [Full Text] [Related]
10. Warfarin pharmacogenetics: ready for clinical utility?
Baudhuin LM
Clin Lab Sci; 2009; 22(3):151-5. PubMed ID: 19827409
[No Abstract] [Full Text] [Related]
11. [Application of warfarin pharmacogenetics].
Tomek A; Mat'oska V; Kumstýrfová T; Táborský L
Vnitr Lek; 2009 Jun; 55(6):565-9. PubMed ID: 19662888
[TBL] [Abstract][Full Text] [Related]
12. Using pharmacogenetics in real time to guide warfarin initiation: a clinician update.
Carlquist JF; Anderson JL
Circulation; 2011 Dec; 124(23):2554-9. PubMed ID: 22144632
[No Abstract] [Full Text] [Related]
13. Pharmacogenetic differences between warfarin, acenocoumarol and phenprocoumon.
Beinema M; Brouwers JR; Schalekamp T; Wilffert B
Thromb Haemost; 2008 Dec; 100(6):1052-7. PubMed ID: 19132230
[TBL] [Abstract][Full Text] [Related]
14. Role of warfarin pharmacogenetic testing in clinical practice.
Tan GM; Wu E; Lam YY; Yan BP
Pharmacogenomics; 2010 Mar; 11(3):439-48. PubMed ID: 20402581
[TBL] [Abstract][Full Text] [Related]
15. Pharmacogenetic-based dosing of warfarin.
Med Lett Drugs Ther; 2008 May; 50(1286):39-40. PubMed ID: 18487958
[No Abstract] [Full Text] [Related]
16. An analysis of the relative effects of VKORC1 and CYP2C9 variants on anticoagulation related outcomes in warfarin-treated patients.
Meckley LM; Wittkowsky AK; Rieder MJ; Rettie AE; Veenstra DL
Thromb Haemost; 2008 Aug; 100(2):229-39. PubMed ID: 18690342
[TBL] [Abstract][Full Text] [Related]
17. Genetic influences on the response to warfarin.
Kamali F
Curr Opin Hematol; 2006 Sep; 13(5):357-61. PubMed ID: 16888441
[TBL] [Abstract][Full Text] [Related]
18. Using genetic testing to guide warfarin therapy.
Ungerer LL; Pestka EL; Messner PK
Nursing; 2012 May; 42(5):63-5. PubMed ID: 22531080
[No Abstract] [Full Text] [Related]
19. Genotype-guided vs clinical dosing of warfarin and its analogues: meta-analysis of randomized clinical trials.
Stergiopoulos K; Brown DL
JAMA Intern Med; 2014 Aug; 174(8):1330-8. PubMed ID: 24935087
[TBL] [Abstract][Full Text] [Related]
20. [Warfarin resistance and related pharmacogenetic information].
Takahashi H
Brain Nerve; 2008 Nov; 60(11):1365-71. PubMed ID: 19069171
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
